Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Total Current Liabilities (2016 - 2025)

Ingevity (NGVT) has disclosed Total Current Liabilities for 11 consecutive years, with $341.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 29.23% to $341.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $341.3 million, a 29.23% increase, with the full-year FY2025 number at $341.3 million, up 29.23% from a year prior.
  • Total Current Liabilities was $341.3 million for Q4 2025 at Ingevity, down from $411.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $551.7 million in Q1 2022 to a low of $224.5 million in Q1 2021.
  • A 5-year average of $319.5 million and a median of $304.3 million in 2022 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: soared 145.75% in 2022, then plummeted 49.47% in 2023.
  • Ingevity's Total Current Liabilities stood at $268.9 million in 2021, then rose by 12.87% to $303.5 million in 2022, then grew by 19.57% to $362.9 million in 2023, then dropped by 27.23% to $264.1 million in 2024, then grew by 29.23% to $341.3 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Total Current Liabilities are $341.3 million (Q4 2025), $411.6 million (Q3 2025), and $393.1 million (Q2 2025).